Verastem, Inc. (VSTM) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Verastem, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Verastem, Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-5.68%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Verastem, Inc. actually do?
Answer:
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing new medicines for challenging RAS/MAPK pathway-driven cancers. The company markets AVMAPKI FAKZYNJA CO-PACK in the U.S., which received accelerated FDA approval in May 2025 for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC). Verastem's pipeline includes clinical-stage programs targeting key signaling pathways in cancer, such as VS-7375, a KRAS G12D inhibitor. The company's strategy centers on precision targeting of these cancers with novel small molecule drugs, aiming to improve patient outcomes. Commercialization efforts are focused on the U.S. market, with plans for potential geographic expansion.
Question:
What are Verastem, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by the sale of AVMAPKI FAKZYNJA CO-PACK in the United States. The company also receives revenue from milestone payments related to the sale of its COPIKTRA license and related assets.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required